Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA00.024a, Reporting Requirements for Drugs and Biologics
Notification: 01/01/2016 | Effective: 03/01/2016 | Posted: 01/05/2016
Type of policy change: This is a new policy.

MA08.011b, Erythropoiesis Stimulating Agents (ESAs)
Notification: 01/11/2016 | Effective: 02/08/2016 | Posted: 01/11/2016
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update

MA11.001a, Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence
Notification: 01/11/2016 | Effective: 02/10/2016 | Posted: 01/11/2016
Type of policy change: Medical Necessity Criteria; General Description, Guidelines, or Informational Update


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA06.010a, Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.037a, Bortezomib (Velcade®)
Notification: 10/07/2015 | Effective: 01/05/2016 | Posted: 01/05/2016
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA07.038b, Neuropsychological Evaluation/Testing
Effective: 01/27/2016 | Posted: 01/27/2016
Type of policy change: General Description, Guidelines, or Informational Update

MA07.013b, Electrical Stimulation and Electromagnetic Stimulation for the Treatment of Wounds
Effective: 01/27/2016 | Posted: 01/27/2016
Type of policy change: General Description, Guidelines, or Informational Update

MA08.008b, Total Parenteral Nutrition (TPN), Intradialytic Nutrition (IDPN), and Intraperitoneal Nutrition (IPN)
Notification: 12/30/2015 | Effective: 01/29/2016 | Posted: 01/29/2016


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA11.070, Lipectomy and Liposuction
Reissue Effective: 01/05/2016 | Reissue Posted: 01/05/2016

MA05.017, Home Oxygen Therapy
Reissue Effective: 12/30/2015 | Reissue Posted: 01/06/2016

MA01.004a, Continuous Local Delivery of Anesthesia to Operative Sites Using an Elastomeric Infusion Pump
Reissue Effective: 01/06/2016 | Reissue Posted: 01/07/2016

MA01.004a, Continuous Local Delivery of Anesthesia to Operative Sites Using an Elastomeric Infusion Pump
Reissue Effective: 01/06/2016 | Reissue Posted: 01/07/2016

MA02.002, Private Duty Nursing
Reissue Effective: 01/06/2016 | Reissue Posted: 01/07/2016

MA02.001, Hospice Care
Reissue Effective: 01/06/2016 | Reissue Posted: 01/07/2016

MA06.006a, Lyme Disease: Diagnosis and Intravenous (IV) Antibiotic Treatment
Reissue Effective: 01/06/2016 | Reissue Posted: 01/07/2016

MA12.001a, Alternative Therapies and Complementary Medicine
Reissue Effective: 01/06/2016 | Reissue Posted: 01/07/2016

MA06.002, In Vitro Allergy Testing
Reissue Effective: 12/30/2015 | Reissue Posted: 01/13/2016

MA11.002b, Hematopoietic Stem Cell Transplantation
Reissue Effective: 12/30/2015 | Reissue Posted: 01/14/2016

MA11.018a, Mohs' Micrographic Surgery (MMS)
Reissue Effective: 12/30/2015 | Reissue Posted: 01/14/2016

MA11.051a, Treatment of Obesity and Bariatric Surgery for Treatment of Morbid Obesity
Reissue Effective: 12/30/2015 | Reissue Posted: 01/14/2016

MA11.047a, Blepharoplasty, Repair of Blepharoptosis, Repair of Brow Ptosis, and Canthoplasty/Canthopexy
Reissue Effective: 12/30/2015 | Reissue Posted: 01/14/2016

MA06.004, In Vivo Allergy Sensitivity Testing
Reissue Effective: 12/30/2015 | Reissue Posted: 01/14/2016

MA06.008, Pharmacogenetic Testing to Determine Drug Sensitivity
Reissue Effective: 12/30/2015 | Reissue Posted: 01/14/2016

MA05.019, Continuous Passive Motion (CPM) Devices in the Home Setting
Reissue Effective: 01/20/2016 | Reissue Posted: 01/20/2016

MA05.008, Negative Pressure Wound Therapy (NPWT) Systems
Reissue Effective: 01/20/2016 | Reissue Posted: 01/20/2016

MA07.015, Evaluation and Management (E&M) of Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS)
Reissue Effective: 01/21/2016 | Reissue Posted: 01/21/2016

MA07.009b, Routine Foot Care For Certain Medical Conditions
Reissue Effective: 01/21/2016 | Reissue Posted: 01/21/2016

MA11.045a, Uterine Artery Embolization
Reissue Effective: 01/21/2016 | Reissue Posted: 01/21/2016

MA11.014b, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Reissue Effective: 01/21/2016 | Reissue Posted: 01/21/2016

MA11.066a, Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome
Reissue Effective: 01/21/2016 | Reissue Posted: 01/21/2016

MA07.025a, Intrauterine Systems (IUSs) (e.g. Mirena®, Skyla®, Liletta®)
Reissue Effective: 01/22/2016 | Reissue Posted: 01/22/2016


Coding Update
The following Medicare Advantage policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
MA08.010c, Programmed Cell Death Receptor-1 (PD-1) antagonists (e.g., Keytruda®, Opdivo®)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.011a, Erythropoiesis Stimulating Agents (ESAs)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.051b, C1 Esterase Inhibitors: Cinryze®, Berinert®, and Ruconest®
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.001a, Vedolizumab (Entyvio®)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.015b, Alemtuzumab (Lemtrada™)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.058a, Blinatumomab (Blincyto™)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.055b, Histone Deacetylase Inhibitors for Peripheral T-cell Lymphoma (e.g. Istodax®, Beleodaq®)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.006b, Siltuximab (Sylvant™)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.007d, Medicare Part B vs. Part D Crossover Drugs
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.079b, Evaluation and Treatment of Erectile Dysfunction (ED)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.008a, Total Parenteral Nutrition (TPN), Intradialytic Nutrition (IDPN) and Intraperitoneal Nutrition (IPN)
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.004c, Coagulation Factors for Hemophilia
Effective: 01/01/2016 | Posted: 01/04/2016

MA08.009a, Immune Globulin: Intravenous (IVIG), Subcutaneous (SCIG)
Effective: 01/01/2016 | Posted: 01/04/2016

MA05.007a, Nebulizers
Effective: 01/01/2016 | Posted: 01/04/2016

MA00.003c, Preventive Care Services
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.088b, Computer-Assisted Musculoskeletal Surgical Navigational Orthopedic Procedure
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.023b, Hyaluronan Acid Therapies for Osteoarthritis of the Knee
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.002b, Hematopoietic Stem Cell Transplantation
Effective: 01/01/2016 | Posted: 01/04/2016

MA09.021a, Magnetic Resonance Imaging (MRI)-Guided Focused Ultrasound Ablation
Effective: 01/01/2016 | Posted: 01/04/2016

MA05.046a, Wheelchair Options/Accessories
Effective: 01/01/2016 | Posted: 01/04/2016

MA05.053b, Implantable and External Infusion Pumps
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.024b, Percutaneous Vertebroplasty and Percutaneous Vertebral Augmentation
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.005a, Deep Brain Stimulation (DBS)
Effective: 01/01/2016 | Posted: 01/04/2016

MA11.015c, Wound Care: Skin Substitutes for the Treatment of Burns and Chronic, Non-Healing Wounds
Effective: 01/01/2016 | Posted: 01/04/2016

MA09.002c, High-Technology Radiology Services
Effective: 01/01/2016 | Posted: 01/04/2016

MA06.013b, Serodiagnosis of Inflammatory Bowel Disease (IBD) and the Prometheus® IBD sgi Diagnostic™ Test
Effective: 01/01/2016 | Posted: 01/05/2016

MA06.023a, Nerve Fiber Density Testing
Effective: 01/01/2016 | Posted: 01/05/2016

MA06.015b, AlloMap™ Molecular Expression Testing for Heart Transplant Rejection
Effective: 01/01/2016 | Posted: 01/05/2016

MA11.051a, Treatment of Obesity and Bariatric Surgery for Treatment of Morbid Obesity
Effective: 01/01/2016 | Posted: 01/05/2016

MA07.048a, Instrument-Based Vision Screening
Effective: 01/01/2016 | Posted: 01/05/2016

MA06.021b, In Vitro Chemosensitivity and Chemoresistance Assays
Effective: 01/01/2016 | Posted: 01/05/2016

MA06.014b, Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) Therapy
Effective: 01/01/2016 | Posted: 01/05/2016

MA06.012b, Genetic Testing for Inherited Susceptibility to Colon Cancer and Microsatellite Instability Testing (Familial Adenomatous Polyposis and Lynch Syndrome)
Effective: 01/01/2016 | Posted: 01/06/2016

MA05.063a, Repair or Replacement of an External Prosthetic Device
Effective: 01/01/2016 | Posted: 01/06/2016

MA07.051a, Intraoperative Neurophysiological Testing
Effective: 01/01/2016 | Posted: 01/06/2016

MA06.025a, Presumptive and Definitive Drug Testing
Effective: 01/01/2016 | Posted: 01/08/2016

MA00.037b, Billing for Professional Office-Based Services Performed in an Outpatient Office-Based Setting Located within a Facility or on a Facility Campus
Effective: 01/01/2016 | Posted: 01/15/2016

MA05.044a, Durable Medical Equipment (DME)
Effective: 01/01/2016 | Posted: 01/22/2016

MA00.010e, PPO Network Rules for Provision of Specialty Services for Durable Medical Equipment and Laboratory, Radiology, and Physical Medicine and Rehabilitative Services
Effective: 01/01/2016 | Posted: 01/25/2016

MA00.030e, Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) Products
Effective: 01/01/2016 | Posted: 01/25/2016


Archived Policies
Independence Blue Cross has determined that it is no longer necessary for the following Medicare Advantage policy to remain active.
MA00.008, Infusion Therapy Services as Performed by Home Infusion Providers
Effective: 01/01/2015 | Posted: 01/05/2016

MA03.004b, Modifier 51: Multiple Procedures
Archive Effective: 02/01/2016 | Posted: 01/05/2016










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.